Skip to main content
. Author manuscript; available in PMC: 2011 May 3.
Published in final edited form as: Clin Cancer Res. 2008 Sep 1;14(17):5602–5609. doi: 10.1158/1078-0432.CCR-08-0433

Table 2.

Dose-escalation and DLT experience

Dose level EKB-569 Dose (mg/d) Capecitabine dose (mg/m2/twice daily) No. of patients No. of cycles No. of patients with DLT
1 25 750 6 131 1 with grade 3 diarrhea
2 50 750 7* 42 1 with grade 3 diarrhea, hypotension, and dehydration
3 50 1,000 20 86 1 with grade 3 diarrhea
4 75 1,000 4 6 1 with grade 3 diarrhea
1 with grade 2 diarrhea and rash
Total 37
*

One patient was removed from the study on cycle 1, day 4 to receive palliative radiation and was not considered evaluable for dose escalation.